Keywords: Acute pancreatitis, drug induced pancreatitis, idiopathic pancreatitis
Published online 2021 July 20. doi: 10.5041/RMMJ.10442.
Clinical Characteristics and Prognosis of Idiopathic Acute Pancreatitis
1Internal Medicine Division F, Soroka University Medical Center, Beer-Sheva, Israel
2Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel
3Rheumatologic Unit, Soroka University Medical Center, Beer-Sheva, Israel
4Department of Emergency Medicine, Soroka University Medical Center, Beer-Sheva, Israel
5Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
*To whom correspondence should be addressed. E-mail: firstname.lastname@example.org
Copyright : © 2021 Barski et al.
This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ObjectiveAcute pancreatitis is a serious diagnosis with an increasing incidence in the Western world. In this study we sought to investigate the incidence of idiopathic AP and to compare clinical and prognostic characteristics of idiopathic cases with cases of AP with known etiology.
MethodsIn this retrospective study of adult hospitalized patients diagnosed with acute pancreatitis between 2012 and 2015, a comparison was made between admissions of patients with known etiology and those for whom no cause was found. Primary outcome was defined as composite outcome of 30-day mortality and complications.
ResultsAmong 560 admissions of 437 patients with a primary diagnosis of acute pancreatitis, the main factors identified were gallstones (51.2%) and idiopathic pancreatitis (35.9%), with alcohol ranked third at only 4.8%. Mortality rate within 30 days of hospitalization was 2.9% and within one year was 7.1%. Use of lipid-lowering, anti-hypertensive, and anti-diabetic medications was more frequent among patients with “idiopathic” disease (70%, 68%, and 33% versus 59%, 56%, and 27%, respectively). Patients admitted with idiopathic AP, in comparison to patients with known AP etiology, had milder disease with shorter hospital stay (3 days versus 4, respectively), and less re-admission in 30 days (7.5% versus 21.2%). Idiopathic AP patients had better prognosis in terms of 30-day death and complication (HR 0.33, 95% CI 0.08–0.40, P<0.001).
ConclusionIdiopathic disease is common among acute pancreatitis patients; the two study groups differed in severity of disease and prognosis. Common use of medications with doubtful value suggests possible under-diagnosis of drug-induced acute idiopathic pancreatitis.
Keywords: Acute pancreatitis, drug induced pancreatitis, idiopathic pancreatitis
Acute pancreatitis (AP) is an acute inflammatory process of the pancreas. Annual incidence of AP is in the range of 4.9–35 cases per 100,000 people, with a mortality rate of between 5% and 10% of hospitalized patients.1–3 In the past few decades there has been an increase of incidence, with a decline in mortality.4 These trends are probably due to increased prevalence of obesity and alcohol consumption, along with better diagnostic methods and improved medical care.3 It is known that the two most common etiologies for AP are obstructive gallbladder disease (up to 40% of AP cases) and alcohol use (up to 30% of AP cases).5,6 Additional but less common etiological factors include hypertriglyceridemia, hypercalcemia, and resulting from endoscopic retrograde cholangiopancreatography (ERCP) and drug reaction, among others.
In the absence of etiology it is possible to perform ERCP including aspiration and microscopic examination of the gall contents, magnetic resonance cholangiopancreatography (MRCP), and high-resolution endoscopic ultrasound (EUS). These methods can help to diagnose microlithiasis and other possible factors causing AP.7,8 Extensive investigation including advanced imaging techniques such as MRCP, ERCP, EUS, manometry, and gall analysis according to the American Gastroenterological Association (AGA) guidelines still leaves 15%–25% of cases as idiopathic.5
In a study from Australia published in 2015, the percentage of AP patients with no identified cause was 25.9%; the authors found no significant prognostic difference between these patients and patients with known etiology.9
In this study we sought to estimate the prevalence of idiopathic AP and to compare clinical and prognostic characteristics of patients hospitalized with an AP diagnosis with known etiology versus idiopathic AP. Furthermore, we intended to follow the group of idiopathic AP patients for a period of one year, to investigate whether etiology for their disease was eventually determined.
Study PopulationThis retrospective cohort study included patients aged 18 and above who had been admitted with a primary diagnosis of acute pancreatitis (ICD-9 code 577.0) in Soroka University Medical Center (SUMC), a tertiary hospital that serves one million residents of the southern region of Israel, during the years 2012–2015.
For each admission, demographic and clinical data were collected, including background diseases, chronic medication use, admission diagnosis, hospitalization vitals, and laboratory and imaging results. Two internal medicine physicians reviewed patients’ files, and for each case the probable etiology of AP was determined. Cases with no known etiology were defined as idiopathic.
Outcome MeasuresPrimary outcome was defined as composite outcome including 30-day mortality, intensive care unit (ICU) admission, complications of pancreatitis (e.g. necrotizing pancreatitis, pseudocyst), surgery due to complications, and 30-day re-admission due to pancreatitis (omitting ambulatory admissions for ERCP or surgery). Secondary outcome was all components of the composite outcome, and long-term (1 year) outcome.
Follow-up“Idiopathic” pancreatitis patients’ medical records were examined for a period of 12 months after discharge in order to ascertain AP etiology in retrospect. During that year, outpatient clinic, imaging, and hospital re-admissions were reviewed.
Statistical AnalysisData are expressed as mean±standard deviation (SD), median±interquartile range (IQR), or number and percentage. We compared patient characteristics between idiopathic versus “non-idiopathic” pancreatitis using t test, chi-square test, and non-parametric test. We used generalized estimating equation (GEE) logistic regression (unstructured matrix) to compare proportions of composite outcome between the two groups. This accounts for the clustering of the same patient composite outcome risk. The final model was selected based on model goodness-of-fit, minimal covariates, and plausible clinical explanation. Statistical analysis was performed using the Statistical Package for Social Sciences for Windows (SPSS), version 25.0 (IBM Corp, Armonk, NY, USA).
The study was approved by the Institutional Review Board prior to its initiation. Confidentiality was maintained throughout the study.
Baseline Patient CharacteristicsBetween the years 2012 and 2015, there were 560 admissions of 437 patients enrolled in the Israeli health maintenance organization, Clalit Health Services, aged 18 and above to SUMC with a primary diagnosis of AP.
The main probable etiologies were gallstones (51.2%) and idiopathic AP (35.9%), with alcohol in third place at only 4.8% of cases (Figure 1). Mean age was 61.9 years, 46.3% were male, and 86% were Jewish. The proportion of patients with Charlson co-morbidity index >1 was 17.7%. Other background diseases are listed in Table 1. According to the modified Glasgow score, 18.4% of cases were classified as severe, and 3.6% suffered complications, the most common of which was necrotizing pancreatitis (2.7%). Of all AP admissions, 2.1% eventually transferred to the intensive care unit.
Comparison between “Idiopathic” AP and “Known Etiology” APIn the idiopathic patients group, the proportion of male patients was significantly higher (52.7% versus 42.6%, P=0.022), as was the trend of a background diagnosis of diabetes mellitus (33.3% versus 25.6% P=0.063). Patients without known etiology were more prone to use medications that interfere with the renin–angiotensin–aldosterone system, as well as anti-diabetic and lipid-lowering medications compared to patients with known etiology.
OutcomesPatients with idiopathic disease, as compared to non-idiopathic AP, had milder disease as reflected by shorter hospital length of stay (3 versus 4 days, P<0.001) and decrease of both short (30-day) and long-term (1-year) re-admission rates (7.5% versus 21.2%, P<0.001; and 28.3% versus 46.5%, P<0.001, respectively) (Table 2).
In univariate analysis (Kaplan–Meier curve), idiopathic disease had better outcome according to significant difference in composite outcome (log rank P<0.001) (Figure 2).
In multivariate analysis, idiopathic disease was associated with better prognosis according to composite outcome (including 30-day mortality, ICU admission, any complication, surgery due to complication, and 30-day re-admission due to pancreatitis) (HR 0.33, 95% CI 0.08–0.40, P<0.001, adjusted to Glasgow score, gender, Charlson index, and lipid-lowering treatment) (Table 3). Cox regression analysis shows that in addition to having unknown etiology (idiopathic disease), positive endpoints were also significantly more common among patients who used lipid-lowering drugs and had a lower modified Glasgow score (Table 3).
1-Year Follow-upDuring 1-year follow-up of idiopathic disease patients, a probable etiology was found only in 15 of these patients (7.5%). Distribution of factors is presented in Table 4.
In this population-based study of hospitalized AP patients, the proportion with idiopathic disease was above one-third. In comparison to known etiology AP patients, patients with idiopathic disease had milder disease with better prognosis in terms of admission stay, and short-term (30-day) and long-term (1-year) re-admissions. Chronic anti-hypertensive and anti-glycemic medication use was more common among idiopathic AP patients. It suggests that there is a possibility of underestimation of drug-induced pancreatitis.
In our study the most common known cause of AP was gallstones, whereas alcohol consumption was a less prevalent factor. This low prevalence is differ-ent compared to most other countries. Previous studies show a variety of factors causing AP, and the variability is explained by differences in lifestyle and habits. Studies have shown that in most European countries and in the United States there are similar rates of AP caused mainly by alcohol and gallstones.5,6,10,11 However, studies carried out in southern European countries such as Greece and Italy show a significant dominance of gallstones as the AP factor.4,12 In this aspect there is a similarity between the population of southern Israel included in this study and the populations of southern Europe/the Mediterranean basin.
The high percentage of patient admissions for idiopathic AP at SUMC during the period of our study may be a result of undiagnosed gallstones, which is recognized as a possible factor in such cases.13,14 Additional possibilities are a reporting bias for alcohol consumption and under-diagnosis of drug reactions.15
Yet, the percentage of patient admissions for idiopathic AP in our study is similar to findings presented in two large studies carried out within the last 10 years in the United States.16,17 In another study 36.5% of patients whose AP had no identified factor had a higher risk of death.18 That study also showed statistical similarities between groups of patients with idiopathic disease and those with biliary disease as factor (predominantly female and older patients). In another study, patients with alcoholic pancreatitis had the highest risk of dying.19
This is the first study to suggest a better prognosis in the subgroup of idiopathic AP, which is mainly expressed in shorter length of hospital stay and lower rates of re-admissions. There was also higher modified Glasgow score and more complications among patients with known etiology compared to patients with idiopathic disease, although this difference was not significant.
As mentioned above, patients with idiopathic disease used more angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, and drugs for diabetes and hyperlipidemia. This significant difference raises the question as to the presence of a causal association between drug use and incidence of idiopathic AP, especially as we note that idiopathic cases tend to be milder than other cases, similar to drug-induced AP which has been shown to have a better prognosis.18 Previous studies have shown that drug-induced AP is a less common form of the disease and is thought to make up only 1%–2% of cases.19,20
However, the acknowledged difficulty to pinpoint a source in every AP case may mean that drug-induced cases are underdiagnosed. We recommend further research to study the association between usage of the aforementioned medications and incidence of AP, in order to support or refute this hypothesis.
The statistical analysis of the study data was carried out not only to determine clinical and prognostic characteristics of idiopathic AP, but also to try and reveal possible etiologies for the disease. Of the patients with idiopathic AP in our study, 33.3% were followed by a gastroenterology physician, and 12.9% underwent advanced imaging tests during the year following hospitalization, which led to a small proportion (7.5%) of the total number of patients having their disease subsequently reclassified with known etiology.
Previous researchers have proposed that idiopathic cases are actually caused by undiagnosed gallstones and have mentioned various incidence statistics.14,21 In order to diagnose whether the source of the illness in these cases is indeed gallstones, various methods can be used: testing for increase in liver enzymes, repeating imaging tests, using advanced imaging such as ERCP, MRCP, and EUS, performing ex vivo bile crystallization, and cholecystectomy.7,8 Another common factor in AP is sphincter of Oddi dysfunction, where the assumption is that increased pressure on the sphincter may cause AP.22 The preferred method of diagnosis in these cases is ERCP plus manometry.23 Additional etiological factors revealed by use of invasive procedures include neoplasia and pancreatic divisum.24
In our study, several idiopathic cases could be reclassified as biliary according to high liver enzymes (ALT>150 U/L).25 Only four additional cases (2%) could be reclassified as caused by gallstones further to data collected from patients during the year following hospitalization. The small number of patients with idiopathic AP who could be reclassified as having gallstones, along with the differences in clinical and prognostic characteristics between groups, creates doubt as to the assumption that the majority of idiopathic cases are actually due to gallstones.
This retrospective study was based on data from a single medical center in Israel. We acknowledge possible underestimation of drug use and alcohol consumption as etiological factors, due to reporting bias. Discharged patients were followed for a relatively short period of 12 months.
In conclusion, idiopathic acute pancreatitis is relatively common among AP patients. According to our study, idiopathic AP seems to be less severe than AP with known etiology. We suggest that a partial explanation for this finding could be the under-diagnosis of drug-induced AP, a milder form of the disease, among patients with no identifying factor. This hypothesis is supported by the increased use of certain drugs in the idiopathic AP group. We recommend that efforts be increased to discover the etiology among idiopathic AP patients. Future research should focus on the use of medication as a possible AP factor.
Sarles H. Revised classification of pancreatitis--Marseille 1984. Dig Dis Sci. 1985;30:573. https://doi.org/10.1007/bf01320265.
Vege, SS.; Yadav, D.; Chari, ST. Pancreatitis. In: Talley NJ, Locke GR III, Saito YA. , editors. Blackwell GI Epidemiology. 1st ed. Malden, MA, USA: Blackwell; 2007. pp. 221–5.
Toouli J, Brooke-Smith M, Bassi C, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002;17:S15–39. https://doi.org/10.1046/j.1440-1746.17.s1.2.x.
Cavallini G, Frulloni L, Bassi C, et al. Prospective multicentre survey on acute pancreatitis in Italy (ProInf-AISP): results on 1005 patients. Dig Liver Dis. 2004;36:205–11. https://doi.org/10.1016/j.dld.2003.11.027.
Forsmark CE, Baillie J. AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–44. https://doi.org/10.1053/j.gastro.2007.03.065.
Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008;168:649–56. https://doi.org/10.1001/archinte.168.6.649.
Buscail L, Escourrou J, Delvaux M, et al. A microscopic examination of bile directly collected during endoscopic cannulation of the papilla. Utility in patients with suspected microlithiasis. Dig Dis Sci. 1992;37:116–20. https://doi.org/10.1007/bf01308353.
Yusoff IF, Raymond G, Sahai AV. A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis. Gastrointest Endosc. 2004;60:673–8. https://doi.org/10.1016/s0016-5107(04)02018-8.
Nesvaderani M, Eslick GD, Vagg D, Faraj S, Cox MR. Epidemiology, aetiology and outcomes of acute pancreatitis: a retrospective cohort study. Int J Surg. 2015;23:68–74. https://doi.org/10.1016/j.ijsu.2015.07.701.
O’Farrell A, Allwright S, Toomey D, Bedford D, Conlon K. Hospital admission for acute pancreatitis in the Irish population, 1997 2004: could the increase be due to an increase in alcohol-related pancreatitis? J Public Health. 2007;29:398–404. https://doi.org/10.1093/pubmed/fdm069.
Beckingham IJ, Bornman PC. ABC of diseases of liver, pancreas, and biliary system: acute pancreatitis. BMJ. 2001;322:595–8. https://doi.org/10.1136/bmj.322.7286.595.
Gullo L, Migliori M, Oláh A, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas. 2002;24:223–7. https://doi.org/10.1097/00006676-200204000-00003.
Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med. 1992;326:589–93. https://doi.org/10.1056/nejm199202273260902.
Ros E, Navarro S, Bru C, Garcia-Pugés A, Valderrama R. Occult microlithiasis in ‘idiopathic’ acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology. 1991;101:1701–9. https://doi.org/10.1016/0016-5085(91)90410-m.
Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C. Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction. 2004;99:1024–33. https://doi.org/10.1111/j.1360-0443.2004.00815.x.
Chen Y, Zak Y, Hernandez-Boussard T, Park W, Visser BC. The epidemiology of idiopathic acute pancreatitis analysis of the nationwide inpatient sample from 1998 to 2007. Pancreas. 2013;42:1–5. https://doi.org/10.1097/MPA.0b013e3182572d3a.
Frey CF, Zhou H, Harvey DJ, White RH. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994–2001. Pancreas. 2006;33:336–44. https://doi.org/10.1097/01.mpa.0000236727.16370.99.
Lankisch PG, Dröge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995;37:565–7. https://doi.org/10.1136/gut.37.4.565.
Sekimoto M, Takada T, Kawarada Y, et al. Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:10–24. https://doi.org/10.1007/s00534-005-1047-3.
Barreto SG, Tiong L, Williams R. Drug-induced acute pancreatitis in a cohort of 328 patients. A single-centre experience from Australia. JOP. 2011;12:581–5. https://doi.org/10.6092/1590-8577/491.
Venu RP, Geenen JE, Hogan W, Stone J, Johnson GK, Soergel K. Idiopathic recurrent pancreatitis. An approach to diagnosis and treatment. Dig Dis Sci. 1989;34:56–60. https://doi.org/10.1007/bf01536154.
Fazel A, Geenen JE, MoezArdalan K, Catalano MF. Intrapancreatic ductal pressure in sphincter of Oddi dysfunction. Pancreas. 2005;30:359–62. https://doi.org/10.1097/01.mpa.0000160278.11086.89.
Elta GH. Sphincter of Oddi dysfunction and bile duct microlithiasis in acute idiopathic pancreatitis. World J Gastroenterol. 2008;14:1023–6. https://doi.org/10.3748/wjg.14.1023.
Lehman GA. Acute recurrent pancreatitis. Can J Gastroenterol. 2003;17:381–3. https://doi.org/10.1155/2003/781237.